| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 04/05/2006 | CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 04/05/2006 | CN1249018C Triaryl methane compounds for sickle cell disease |
| 04/05/2006 | CN1248738C Testosterone ester formulation for human use |
| 04/05/2006 | CN1248733C Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 04/05/2006 | CN1248731C Combined application of tumor suppressor gene therapy and chemotherapy in preparation of pharmaceutical composition for treating tumor |
| 04/05/2006 | CN1248730C Chinese medicine for treating enteritis |
| 04/05/2006 | CN1248726C Pharmaceutical composition for treating cancer and its preparation method |
| 04/05/2006 | CN1248723C Medicinal liquor for rheumatism and preparation method thereof |
| 04/05/2006 | CN1248718C Medicinal composition for treating mycoplasma pneumonia and preparation method and quality-control method |
| 04/05/2006 | CN1248712C Medicine composition for treating splenomegaly and its preparation method |
| 04/05/2006 | CN1248706C Pillworm application in preparation of medicine to treat osteoproliferation |
| 04/05/2006 | CN1248697C Medicinal composition for treating chronic enteritis and its preparing process |
| 04/05/2006 | CN1248696C Quality control method of isatis root preparation |
| 04/05/2006 | CN1248693C Sustained release formulation of glucosamine salt and preparation |
| 04/05/2006 | CN1248692C Use of corpus vitreum conjugated protein receptor antagon in preparation of medicine for inhibiting accretion generation |
| 04/05/2006 | CN1248691C Controlled release peroral compositions of levosimendan |
| 04/05/2006 | CN1248690C Oral preparation containing ranolazine hydrochloride for treating cardiovascular disease |
| 04/05/2006 | CN1248689C Injectable bupernorphine microparticle compositions and their use |
| 04/05/2006 | CN1248688C Targeted freeze dried nanometer powder injection of hydroxycamptothecine bean phospholipid and its preparation method |
| 04/05/2006 | CN1248687C Emergency protective agent for wound |
| 04/05/2006 | CN1248686C Application of 5-amino-levulinic acid in swine growth promoters |
| 04/05/2006 | CN1248685C Analgesic/anti-inflammatory patches for topical use |
| 04/05/2006 | CN1248684C Chinese medicine powder for treating cardiovascular and cerebrovascular disease and preparing method thereof |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1248681C Solid orally-dispersible pharmaceutical formulation |
| 04/05/2006 | CN1248680C Injectable composition of paclitaxel |
| 04/05/2006 | CN1248677C Pharmaceutical and cosmetic compositions for protection of skin from damages induced by sun radiations |
| 04/04/2006 | USRE39056 4-Azasteroids for treatment of hyperandrogenic conditions |
| 04/04/2006 | USRE39055 Hepatoselective pharmaceutical actives |
| 04/04/2006 | US7022882 Peptide-free N-methyl-D aspartate receptor open channel blocker which mitigates excitotoxicity to aid in preventing neuronal cell death |
| 04/04/2006 | US7022881 formed by spray drying an aqueous solution, heating/crystallization, suspension/filtration, or acidification/filtration |
| 04/04/2006 | US7022880 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid compounds prepared by acylation of a substituted piperidine derivative; intermediates to terfenadine carboxylic acid metabolite and related compounds |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022855 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022850 Bicyclicpyrimidones and their use to treat diseases |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022846 Metabolites of prinomastat and their synthesis |
| 04/04/2006 | US7022840 Porphyrin array exhibiting large two photon absorption property and including, as structural unit, bis (imidazolylporphyrin metal complex) linked with acetylenic bond and the derivative thereof, and method of producing the same |
| 04/04/2006 | US7022834 nucleotide synthesis; for measuring cellular proliferation and/or destruction rates by measuring DNA synthesis; mammalian cancer cells or cells infected with human immunodeficiency virus (HIV) |
| 04/04/2006 | US7022832 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma |
| 04/04/2006 | US7022830 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/04/2006 | US7022829 MurC gene and enzyme of Pseudomonas aeruginosa |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022740 Lubricious ophthalmic solutions |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022737 Mammals are treated for infections or for conditions associated with pathologically proliferating mammalian cell growth (for example certain cancers, restenosis, benign prostatic hypertrophy) by administration of a manipulator of |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022733 Estrogen receptor modulators for treating or inhibiting endometriosis |
| 04/04/2006 | US7022732 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022728 Administering to a mammal a benzimidazle containing alkylpiperazine or piperidine ring for treatment of sexul disorder |
| 04/04/2006 | US7022727 From amorphous 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; agonising an adenosine receptor; easily purified, stable, easily micronized for inhalants |
| 04/04/2006 | US7022726 ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/04/2006 | US7022725 Isoxazole derivatives |
| 04/04/2006 | US7022724 Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022721 3-carboxymethyl-thiazolium derivatives, 2 substituted by alkyl, 1-hydroxyalkyl, or 1-benzoyloxyalkyl; uncoupling sugar-mediated coupling of proteins, lipids, nucleic acids, resulting from reaction with glucose and other reducing sugars; changing deformability, increase the tissue diffusion coefficient |
| 04/04/2006 | US7022720 Synthetic diazonamides as novel anti-mitotic agents |
| 04/04/2006 | US7022719 Comprises 3-(2-phenyl-2-oxoethyl)-4,5-dimethylthiazolium chloride; for inhibiting protein aging/non-enzymatic crosslinking; immunoassays; for treatment of cataracts |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022714 e.g., 3-(2-piperidinylethyl)-2-(4-phenoxyphenyl)benzimidazole and 3-(2-piperidinylethyl)-2-(N-ethyl-3-carbazolyl)benzimidazole; functions as an antitinnitus agent, anticonvulsant, antiarrhythmic, local anesthetic, or antimanic depressant. |
| 04/04/2006 | US7022713 administering synergistically pravastatin and eicosapentaenoic acid for lowering cholesterol and triglyceride levels in blood |
| 04/04/2006 | US7022712 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022709 Producing pharmaceuticals for improving perception, concentration, learning and/or memory. |
| 04/04/2006 | US7022708 Serotonin receptors antagonis; antidepressants; central nervous system disorders; Parkinson's disease; huntington's disease; Alzheimer's disease |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022705 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics |
| 04/04/2006 | US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor |
| 04/04/2006 | US7022703 Acetylenic compound useful in treating inflammatory disorders |
| 04/04/2006 | US7022702 Antiproliferative 1,2,3-thiadiazole compounds |
| 04/04/2006 | US7022701 for treatment of disorders (sleeping, feeding) relating to or affected by the 5-HT6 receptor; serotonin receptor antagonists |
| 04/04/2006 | US7022700 Neutropenia: oral administration |
| 04/04/2006 | US7022699 Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 04/04/2006 | US7022698 Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof |
| 04/04/2006 | US7022697 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022695 Thioether-substituted benzamides as inhibitors of Factor Xa |
| 04/04/2006 | US7022694 Indoles and indolines having 5-HT activity |
| 04/04/2006 | US7022693 Treatment of lipodystrophy |
| 04/04/2006 | US7022692 comprises water soluble binder and sweetener; for treating central nervous system disorders such as psychotic disease conditions including schizophrenia |
| 04/04/2006 | US7022691 Penicillinate compounds; bactericides for use against antibiotic resistant bacteria |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |